Published in AIDS Weekly, August 24th, 1998
Under the terms of the five-year agreement, Rela manufactures an automated high-throughput DNA probe instrument system, known as Tigris, for blood screening and diagnostic applications.
Rela and Gen-Probe are completing the development of the Tigris system under a separate contract announced previously. Commercial production of the Tigris system is anticipated to begin during 1999.
Gen-Probe was awarded a contract from the U.S. National Heart, Lung and Blood Institute (NHLBI), which is an arm of the U.S....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.